{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T20:36:14Z","timestamp":1719261374266},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.eimc.2011.05.006","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T21:50:38Z","timestamp":1312667438000},"page":"615-625","source":"Crossref","is-referenced-by-count":4,"title":["Prevenci\u00f3n de la transmisi\u00f3n del VIH (vertical, ocupacional y no ocupacional)"],"prefix":"10.1016","volume":"29","author":[{"given":"Harkaitz","family":"Azkune","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maialen","family":"Ibarguren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xabier","family":"Camino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Iribarren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2011.05.006_bib0005","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric aids clinical trials group protocol 076 study group","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0010","unstructured":"Unaids report on the global AIDS epidemic-2010. Disponible en: http:\/\/www.unaids.org\/documents\/20101123_globalreport_em.pdf."},{"key":"10.1016\/j.eimc.2011.05.006_bib0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00042560-199504120-00011","article-title":"Rates of mother-to-child transmission of HIV-1 in Africa. America, and Europe: results from 13 perinatal studies","volume":"8","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.eimc.2011.05.006_bib0020","unstructured":"Vigilancia epidemiol\u00f3gica del sida en Espa\u00f1a. Registro nacional de casos de sida [actualizaci\u00f3n 30\/6\/2010]. Disponible en: http:\/\/www.isciii.es\/htdocs\/centros\/epidemiologia\/pdf\/spns_informe_semestral.pdf."},{"key":"10.1016\/j.eimc.2011.05.006_bib0025","doi-asserted-by":"crossref","unstructured":"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465.","DOI":"10.1086\/427287"},{"key":"10.1016\/j.eimc.2011.05.006_bib0030","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/QAD.0b013e32833e5043","article-title":"Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load","volume":"24","author":"Cu-Uvin","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2011.05.006_bib0035","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.fertnstert.2008.04.013","article-title":"Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection","volume":"91","author":"Sauer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eimc.2011.05.006_bib0040","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/QAD.0b013e3282703879","article-title":"Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the european creathe network","volume":"21","author":"Bujan","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2011.05.006_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4414\/bms.2008.13252","article-title":"Les persones seropositives ne souffrant d\u2019aucune autre MST et suivant un traitement antiretroviral efficace ne trasmettent pas le VIH par voie sexuelle","volume":"89","author":"Vernazza","year":"2008","journal-title":"Bull Med Suisses"},{"key":"10.1016\/j.eimc.2011.05.006_bib0050","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.qai.0000243091.40490.fd","article-title":"Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy","volume":"43","author":"Barreiro","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2011.05.006_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.medcli.2009.02.024","article-title":"HIV sexual transmission. Should we review the risk among individuals with long-term viral supression?","volume":"134","author":"Romeu","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.eimc.2011.05.006_bib0060","unstructured":"Recomendaciones para el seguimiento de la infecci\u00f3n por el VIH con relaci\u00f3n a la reproducci\u00f3n, el embarazo y la prevenci\u00f3n de la transmisi\u00f3n vertical. Disponible en: http:\/\/www.gesida.seimc.org\/index.asp."},{"key":"10.1016\/j.eimc.2011.05.006_bib0065","unstructured":"Panel on treatment of HIV-infected pregnant woman and prevention of perinatal transmission. Recomendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. May 24, 2010. Disponible en: http:\/\/aidsinfo.nih.gov\/contentfiles\/perinatalgl.pdf."},{"key":"10.1016\/j.eimc.2011.05.006_bib0070","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJM200010053431401","article-title":"A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV prevention trial (Thailand) investigators","volume":"343","author":"Lallemant","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0075","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(98)08084-2","article-title":"Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2011.05.006_bib0080","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199904013401301","article-title":"The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0085","doi-asserted-by":"crossref","unstructured":"Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies 1. AIDS. 2001;15:357\u201368.","DOI":"10.1097\/00002030-200102160-00009"},{"key":"10.1016\/j.eimc.2011.05.006_bib0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajog.2005.06.045","article-title":"Prenatal diagnosis in human immunodeficiency virus-infected women: a new screening program for chromosomal anomalies 2","volume":"194","author":"Coll","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2011.05.006_bib0095","unstructured":"Polo R, Aguirrebengoa K, Vives N, coordinadores. Recomendaciones del SPNS, GESIDA, CEESCAT, SEIP Y AEP sobre profilaxis postexposici\u00f3n frente al VIH, VHB y VHC en adultos y ni\u00f1os. Disponible en: http:\/\/www.gesida.seimc.org\/pcientifica\/fuentes\/dcyrc\/gesida_dcyrc200801_profilaxispostexposicion.pdf 2008."},{"key":"10.1016\/j.eimc.2011.05.006_bib0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2334-8-142","article-title":"High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India","volume":"8","author":"Gupta","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimc.2011.05.006_bib0105","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-113-10-740","article-title":"Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A Prospective Evaluation","volume":"113","author":"Henderson","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0110","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1056\/NEJMoa070378","article-title":"Needlestick injuries among surgeons in training","volume":"356","author":"Makary","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0115","first-page":"1","article-title":"Updated U.S. public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis","volume":"54","author":"Panlilio","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.eimc.2011.05.006_bib0120","unstructured":"HIV prophylaxis folllowing occupational exposure [actualizado 10\/5\/2010]. Disponible en: http:\/\/www.hivguidelines.org\/clinical-guidelines\/post-exposure-prophylaxis\/hiv-prophylaxis-following-occupational-exposure\/."},{"key":"10.1016\/j.eimc.2011.05.006_bib0125","unstructured":"Documento de consenso de GESIDA\/Plan nacional sobre el sida respecto al tratamiento antirretroviral en adultos infectados por el virus de inmunodeficiencia humana [actualizado enero 2011]. Disponible en: http:\/\/www.gesida.seimc.org\/pcientifica\/fuentes\/dcyrc\/gesidadcyrc2011-documentoconsenso-tar-adulto-verordenador.pdf."},{"key":"10.1016\/j.eimc.2011.05.006_bib0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(97)89441-7","article-title":"Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview","volume":"102","author":"Bell","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0135","unstructured":"Updated U.S. public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2001;50:1\u201352."},{"key":"10.1016\/j.eimc.2011.05.006_bib0140","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1056\/NEJMcp0904189","article-title":"Clinical practice. Postexposure prophylaxis for HIV infection","volume":"361","author":"Landovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0145","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for disease control and prevention needlestick surveillance group","volume":"337","author":"Cardo","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/infdis\/163.3.625","article-title":"Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-HU mice in a time-dependent manner","volume":"163","author":"Shih","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2011.05.006_bib0155","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/AAC.36.11.2381","article-title":"Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3\u2019-azido-3\u2019-deoxythymidine prevents SIV infection","volume":"36","author":"Van Rompay","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2011.05.006_bib0160","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMra013338","article-title":"Management of human immunodeficiency virus infection in pregnancy","volume":"346","author":"Watts","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0165","unstructured":"Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures-worldwide, 1997-2000. MMWR Morb Mortal Wkly Rep. 2001;49:1153\u201356."},{"key":"10.1016\/j.eimc.2011.05.006_bib0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00126334-200402010-00003","article-title":"Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals","volume":"35","author":"Patel","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2011.05.006_bib0175","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","article-title":"Effectiveness of postinoculation (r)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus sivmne infection depends critically on timing of initiation and duration of treatment","volume":"72","author":"Tsai","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.eimc.2011.05.006_bib0180","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the united states: recommendations from the U.S. department of health and human services","volume":"54","author":"Smith","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.eimc.2011.05.006_bib0185","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199704103361512","article-title":"Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use","volume":"336","author":"Katz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0002-9343(99)00018-2","article-title":"Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault","volume":"106","author":"Bamberger","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0195","doi-asserted-by":"crossref","DOI":"10.3310\/hta13140","article-title":"Non-occupational postexposure prophylaxis for HIV: a systematic review","volume":"13","author":"Bryant","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.eimc.2011.05.006_bib0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1473-3099(08)70156-7","article-title":"Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis","volume":"8","author":"Powers","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2011.05.006_bib0205","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1473-3099(09)70021-0","article-title":"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies","volume":"9","author":"Boily","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2011.05.006_bib0210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00126334-200404150-00010","article-title":"Behavioral impact, acceptability, and hiv incidence among homosexual men with access to postexposure chemoprophylaxis for HIV","volume":"35","author":"Schechter","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2011.05.006_bib0215","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1097\/00002030-200410210-00011","article-title":"Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the united states","volume":"18","author":"Pinkerton","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2011.05.006_bib0220","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0002-9378(99)70529-6","article-title":"The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination","volume":"181","author":"Bloch","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2011.05.006_bib0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/0003-4819-133-1-200007040-00005","article-title":"Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis","volume":"133","author":"Katzenstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archinte.164.1.46","article-title":"Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus","volume":"164","author":"Pinkerton","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2011.05.006_bib0235","unstructured":"Interim Guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60:65\u20138."},{"key":"10.1016\/j.eimc.2011.05.006_bib0240","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1371\/journal.pctr.0020027","article-title":"Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial","volume":"2","author":"Peterson","year":"2007","journal-title":"Plos Clin Trials"},{"key":"10.1016\/j.eimc.2011.05.006_bib0245","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.eimc.2011.05.006_bib0250","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X11001698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X11001698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T02:53:32Z","timestamp":1592794412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X11001698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0213005X11001698"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2011.05.006","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}